{"id":"W2020640954","doi":"10.1053/j.gastro.2013.06.010","title":"Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis","year":2013,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":719,"is_retracted":false,"has_abstract":false,"ca_institutions":"Western University","funders":"Janssen Pharmaceuticals; Janssen Research and Development","keywords":"Golimumab; Ulcerative colitis; Medicine; Internal medicine; Gastroenterology; Colitis; Dermatology; Adalimumab; Rheumatoid arthritis; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005369125292574193,"score_gpt":0.2333681337669594,"score_spread":0.2279990084743853,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}